Clinical Trial Update: Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating induction with or without granulocyte colony-stimulating factor in AML transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Turkish Leukemia Study Group | Conditions: AML | Phase 3 | Status: COMPLETED